Abstract
Reduced GABA concentrations at rest in the fronto-striatal circuitry are repeatedly implicated in cognitive symptoms of ADHD. However, recent evidence has suggested that GABA and its precursor, glutamate, are capable of undergoing dynamic modifications in response to environments. Yet, it remains unclear how the dynamics between glutamate and GABA may change when people are exerting their control of attention, and whether they would predict attention control deficits in ADHD. To study this question, we used MR spectroscopy to quantify GABA and glutamate+glutamine (Glx) concentrations in the anterior cingulate cortex (ACC) and the caudate nucleus in the fronto-striatal circuitry while subjects were performing attention control tasks. We studied 19 adults with ADHD (31-51 years) and 16 adults without ADHD (28-54). We found GABA and Glx concentrations during the tasks increased in both subjects with or without ADHD, but the extent of increases was significantly reduced in subjects with ADHD. Notably, E/I ratios (Glx/GABA) also increased and significantly predicted error rates while subjects with or without ADHD performed the Stroop and Flanker tasks. Critically, regression models including E/I ratios, GABA concentrations, and the ADHD diagnosis significantly predicted task performance in these tasks. Furthermore, clear interactions among these factors predicted the impaired attention control in the Flanker task in subjects with ADHD. These findings demonstrate for the first time that E/I ratios in the ACC and the caudate nucleus increased when people exerted their control of attention, and suggest that reduced GABA contribution to E/I ratio in these two brain regions may account for cognitive deficits in ADHD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by The Paros Brain Research Fund, NIH R01 EB016089, P41 EB015909 R01 DC013260, 1R34MH099208, and Grant ID IIR-USA-001073 by Shire Development LLC.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All experimental procedures were approved by the University of Washington Institutional Review Board and conformed to the ethical principles for research on human subjects from the Declaration of Helsinki, as revised in 2008. All subjects gave written consent to participate in the study
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be available upon request
Abbreviations
- ADHD
- Attention-Deficit/Hyperactivity Disorder
- ACC
- Anterior Cingular Cortex
- Glx
- glutamate/glutamine
- GM
- Grey Matter
- MEGA-PRESS
- MEshcher-GArwood Point RESolved Spectroscopy
- MPRAGE
- Magnetization -prepared rapid gradient
- PFC
- Prefrontal Cortex
- TE
- Echo Time
- TR
- Repetition Time
- WM
- White Matter
- NAA
- acetylaspartate
- NAAG
- acetylaspartylGlu
- FWHM
- full width half maximum
- CRLB
- Cramer-Rao lower bound